An Active-Control, Randomized, Prospective, Multicenter, Phase-III Comparative Clinical Study to investigate, Efficacy, Safety and Tolerability of Linezolid 1200mg SR Tablet OD when compared with Linezolid 600mg Tablet BD in subjects suffering with Uncomplicated Skin and Soft Tissue Infections
Latest Information Update: 30 Aug 2016
At a glance
- Drugs Linezolid (Primary)
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Registrational; Therapeutic Use
- Sponsors Inventia Healthcare
Most Recent Events
- 29 Sep 2013 New trial record